Nam Jung Woo
Department of Oral and Maxillofacial Surgery, Yonsei University College of Dentistry, Seoul, South Korea Department of Oral and Maxillofacial Surgery, Wonkwang University Sanbon Hospital, Gunpo-si, Republic of Korea.
J Craniofac Surg. 2018 May;29(3):772-773. doi: 10.1097/SCS.0000000000004437.
Spontaneous palatal perforation can be rarely developed by several causes, such as tumor, trauma, and infection. This article reports a patient with large mid-palatal perforation after suffering from severe oral mucositis, which occurred about a month after taking methotrexate (MTX) for rheumatoid arthritis. Through computed tomography and clinical examination, this patient was diagnosed with perforation in unrecognized submucous cleft palate (SMCP) due to drug-induced mucositis. After MTX discontinuation, the oral mucositis was almost healed completely in a month, and the hole was successfully closed by palatoplasty. The author can see that the palatal perforation can occur by oral complication of MTX in SMCP patient. It is an important awareness to dentists as the use of MTX continues to increase for antirheumatic therapy.
自发性腭穿孔可由多种原因引起,如肿瘤、创伤和感染,较为罕见。本文报告1例类风湿关节炎患者服用甲氨蝶呤(MTX)约1个月后发生严重口腔黏膜炎,继而出现腭中大型穿孔。通过计算机断层扫描和临床检查,该患者被诊断为药物性黏膜炎导致的隐性黏膜下腭裂(SMCP)穿孔。停用MTX后,口腔黏膜炎在1个月内基本完全愈合,穿孔通过腭成形术成功闭合。作者发现,MTX的口腔并发症可导致SMCP患者发生腭穿孔。随着MTX在抗风湿治疗中的使用不断增加,这对牙医来说是一个重要的认识。